12 competitors and alternatives to gene editing companies — out of roughly 287 similar companies worldwide. Data is AI-generated and may be approximate.
Explore & filter these companies interactively →Leading gene editing company developing CRISPR-based medicines for serious diseases including sickle cell disease and beta thalassemia.
Expertise: CRISPR/Cas9 gene editing, Hemoglobinopathies, Immuno-Oncology, Autoimmune diseases, In Vivo gene editing, Regenerative Medicine
CRISPR-based gene editing company developing medicines for serious genetic diseases.
Expertise: CRISPR/Cas9 gene editing, Hemoglobinopathies, In Vivo gene editing, Immuno-Oncology, Regenerative Medicine
Gene editing company developing CRISPR-based therapies for genetic and acquired diseases.
Expertise: CRISPR/Cas9 gene editing, In Vivo gene editing, Hemoglobinopathies, Immuno-Oncology, Regenerative Medicine
Biopharmaceutical company developing cell and gene therapies for serious genetic diseases.
Expertise: Gene therapy, CRISPR applications, Hemoglobinopathies, Cell therapy, Regenerative Medicine
Gene editing company using zinc finger nucleotide technology for serious genetic diseases.
Expertise: Zinc finger nucleotides, Gene editing, Hemoglobinopathies, In Vivo gene therapy, Immunology
Base editing gene therapy company treating genetic diseases with precision editing technology.
Expertise: Base editing, Gene editing, Hemoglobinopathies, In Vivo gene therapy, Immuno-Oncology
Gene therapy company focused on rare blood disorders and severe genetic diseases.
Expertise: Gene therapy, cell therapy, lentiviral vectors, blood disorders
CRISPR-based gene editing company developing in vivo therapies for serious genetic diseases.
Expertise: CRISPR gene editing, in vivo therapeutics, genetic disorders, oncology
RNA therapeutics company developing exon-skipping treatments for muscular dystrophy and rare genetic diseases.
Expertise: Exon-skipping technology, genetic disorders, RNA therapeutics, muscular dystrophy
Develops mRNA therapeutics for genetic and rare diseases, acquired by Sanofi.
Expertise: mRNA therapeutics, Genetic medicine, Rare diseases, Protein replacement
Develops CRISPR-based therapies targeting chronic viral infections like herpes and HIV.
Expertise: Gene editing, Chronic viral infections, CRISPR-Cas, Herpes therapy
Develops proprietary gene therapy platform for monogenic and metabolic diseases.
Expertise: Gene therapy, Gene editing, Metabolic diseases, Genetic disorders
